Search results
Carol McGiffin health woes throughout the years - from breast cancer diagnosis to mental health
Hello!· 3 days agoFormer Loose Women presenter Carol McGiffin recently celebrated ten years cancer free. Carol was...
Homes Under the Hammer's couple spends £1m on unseen property
Daily Mail· 3 days agoThis is shaped to the size of the tumour and spares the surrounding normal tissue and organs as much...
Botox is out & razors too, here’s what skincare WILL look like in years to come
The Irish Sun· 3 days agoSharon Hilditch, who founded British brand Crystal Clear Skincare almost three decades ago, has been watching the evolving trends for years. Futurist Sharon reveals why multi-purpose pills and ...
Botox is out & razors too, here’s what skincare WILL look like in years to come
The Sun· 3 days agoBut as it is used more and more, I’ve realised what a huge difference it can make to the skin. “It...
'I was 37 and had no symptoms. It's like it's not really happening'
Manchester Evening News via Yahoo News UK· 3 days agoHelen went on to try seven different types of treatment but nothing helped stop the cancer growth....
IceCure Medical (ICCM) New Cryoablation System Gets FDA Nod
Zacks via Yahoo Finance UK· 3 days agoIceCure Medical's (ICCM) XSense Cryoablation System receives FDA approval, marking a pivotal step in...
'Phenomenal' Exmouth mum given devastating news after seizure
Devon Live via Yahoo News UK· 3 days agoCharlie's cousin Jaimie Jones told DevonLive that the mum-of-two has sadly been given a "pretty poor...
Ozempic, Wegovy tied to rare condition that causes one-eye blindness, study says
Euronews via Yahoo News UK· 3 days agoResearchers identified a possible link between semaglutide and a rare eye condition but said more...
Natera (NTRA) Soared After a 43% Increase In Revenue
Insider Monkey via Yahoo Finance UK· 3 days agoArtisan Partners, an investment management company, released its “Artisan Global Equity Fund” first quarter 2024 investor letter. A copy of the letter...
Boosting liver regeneration: kinase inhibitor as a new tool to prevent liver failure - Signal...
Nature· 4 days agoAssessment of the outcome can be challenging due to heterogenous pathologies and interventions, but 5-year survival rates around 50% were...